Tag: FDA
Browse by:
- ServicesStrategic Partnerships & Global EngagementClimate & BiodiversityCapital MarketsChange & TransformationPublic Affairs & Government RelationsInternal Culture & EngagementCompetition and M&ASocial Impact & ESGIntegrated MediaAdvocacy CampaignsExecutive PositioningReputation & Brand ManagementResearch, Analytics and MeasurementCrisis, Issues & LitigationCreative Strategy & DesignCorporate CommunicationGeo-Commerce & Risk
- Sectors
- Regions
Profile of FDA Commissioner Nominee Martin Makary
Martin (Marty) Makary is a surgeon and public policy researcher at Johns Hopkins in Baltimore. He is also a prolific author and has been in the forefront of public commentary on the health care system for several years....
The Food and Drug Administration in the Trump Administration
Elections impact health and regulatory policy. This year's Trump election and new Republican majorities could affect the FDA and industries it regulates. Here are 10 key observations on these potential changes....
FDA Ain’t Broke, Doesn’t Need Fixin’
The FDA ain’t broke, and it doesn’t need much fixin’. This is a message that is being delivered to the Trump administration from all stakeholders including the regulated industry itself, which hopefully will fall on open ears....
FDA is Breaking Record New Drug Approvals
The U.S. Food and Drug Administration (FDA) is setting a remarkable record for new drug approvals in 2018. As of November 1, 2018, 47 new drugs were approved by the FDA exceeding the previous record in 2017 of 46 new drugs. ...